Standardize and enhance the diagnosis and treatment capabilities of chronic lymphoblastic leukemia in China.
10.3760/cma.j.issn.0253-2727.2023.04.001
- Author:
Lu Gui QIU
1
;
Jian Yong LI
2
Author Information
1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.
2. The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Leukemia, Lymphocytic, Chronic, B-Cell;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy*;
China
- From:
Chinese Journal of Hematology
2023;44(4):265-266
- CountryChina
- Language:Chinese
